DSKYF

DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF)

About DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF)

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Details

Daily high

$22.79

Daily low

$21.16

Price at open

$22.50

52 Week High

$30.60

52 Week Low

$19.85

Market cap

41.6B

Dividend yield

2.06%

Volume

33,119

Avg. volume

29,943

P/E ratio

22.35

DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. News